Login to Your Account



Albireo, Ferring Ink Deal for Constipation Drug Elobixibat

By Cormac Sheridan
Staff Writer

Thursday, July 5, 2012
Albireo AB licensed its constipation drug elobixibat to Ferring Pharmaceuticals SA for an undisclosed up-front fee, plus milestones and tiered double-digit royalties. Terms were not disclosed, but Ferring, of Saint-Prex, Switzerland, said it was one of its biggest product investment deals.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription